Ministers in the UK have secured new contracts to buy 114m more Covid-19 vaccines for the next two years.
The deals, for 2022 and 2023, were accelerated after the emergence of the Omicron coronavirus variant, officials said. Under the agreements, the UK will buy 54m more doses from Pfizer/BioNTech and 60m more doses from Moderna.
These purchases are in addition to the 35m extra Pfizer/BioNTech doses ordered in August for delivery in the second half of 2022, officials said. The UK is also still expecting 60m Novavax and 7.5m GSK/Sanofi doses in 2022.
Sajid Javid, the health secretary, said the new deals would “future proof” the UK’s vaccine programme and ensure protection for “even more people in the years ahead”.
There remains uncertainty about
Read more on theguardian.com